Compare BIO-TECHNE Corp (TECH) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Tencent Music Entertainment Group - ADR — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.37B), while Tencent Music Entertainment Group - ADR trades at $8.03 (market cap $12.92B). The key difference: BIO-TECHNE Corp and Tencent Music Entertainment Group - ADR are close in size by market cap, and Tencent Music Entertainment Group - ADR pays the higher dividend (3%). Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and Tencent Music Entertainment Group - ADR for 67 Days on average.
| TECH | TME | |
|---|---|---|
Market Cap | $11.37B | $12.92B |
Volume | 3,153,511 | 2,681,529 |
Sector | Health | Media |
52-Week High | $72.61 | $23.71 |
52-Week Low | $43.31 | $7.74 |
Typical Hold Time | 63 Days | 67 Days |
Enterprise Value | $11.40B | $10.86B |
Dividend Yield | 0.44% | 3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
Tencent Music Entertainment (TME) trades at $7.99, up 0.76% with bearish technical signals despite attractive valuation metrics including a P/E of 9.37 and P/S of 2.47. The company reported strong revenue growth to $32.9B in 2025 with net income reaching $11.06B, though recent quarterly earnings showed mixed results with two misses and one beat against expectations. Analyst consensus remains cautiously optimistic with a $12.50 price target representing 56% upside potential.
TME presents a compelling value opportunity with strong profitability margins and cash flow generation, though facing headwinds from intensifying competition and slowing user growth. The company's $400 million share repurchase program and recent $1 billion notes offering demonstrate financial discipline, but regulatory oversight and competitive pressures from short-form video platforms remain key risks for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →
